Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women
CYP2E1 enzyme is related to nonalcoholic steatohepatitis (NASH) due to its ability for reactive oxygen species production, which can be influenced by polymorphisms in the gene. The aim of this study was to investigate hepatic levels, activity, and polymorphisms of the CYP2E1 gene to correlate it wit...
Guardado en:
Autores principales: | , , , , , , , , |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2008
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602008000100010 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0716-97602008000100010 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0716-976020080001000102008-08-21Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese WomenVARELA,NELSON MQUIÑONES,LUIS AORELLANA,MYRIAMPONIACHIK,JAIMECSENDES,ATTILASMOK,GLADYSRODRIGO,RAMÓNCÁCERES,DANTE DVIDELA,LUIS A steatohepatitis NASH CYP2E1 obesity genotype chlorzoxazone CYP2E1 enzyme is related to nonalcoholic steatohepatitis (NASH) due to its ability for reactive oxygen species production, which can be influenced by polymorphisms in the gene. The aim of this study was to investigate hepatic levels, activity, and polymorphisms of the CYP2E1 gene to correlate it with clinical and histological features in 48 female obese NASH patients. Subjects were divided into three groups: (i) normal; (ii) steatosis; and (iii) steatohepatitis. CYP2E1 protein level was assayed in microsomes from liver biopsies, and in vivo chlorzoxazone hydroxylation was determined by HPLC. Genomic DNA was isolated for genotype analysis through PCR. The results showed that liver CYP2E1 content was significantly higher in the steatohepatitis (45%; p=0.024) and steatosis (22%; p=0.032) group compared with normal group. Chlorzoxazone hydroxylase activity showed significant enhancement in the steatohepatitis group (15%, p=0.027) compared with the normal group. c2 rare allele of RsallPstl polymorphisms but no C allele of Dral polymorphism was positively associated with CHZ hydroxylation, which in turn is correlated with liver CYP2E1 content (r=0.59; p=0.026). In conclusion, c2 allele is positively associated with liver injury in NASH. This allele may determine a higher transcriptional activity of the gene, with consequent enhancement in pro-oxidant activity of CYP2E1 thus affording liver toxicityinfo:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.41 n.1 20082008-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602008000100010en10.4067/S0716-97602008000100010 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
English |
topic |
steatohepatitis NASH CYP2E1 obesity genotype chlorzoxazone |
spellingShingle |
steatohepatitis NASH CYP2E1 obesity genotype chlorzoxazone VARELA,NELSON M QUIÑONES,LUIS A ORELLANA,MYRIAM PONIACHIK,JAIME CSENDES,ATTILA SMOK,GLADYS RODRIGO,RAMÓN CÁCERES,DANTE D VIDELA,LUIS A Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women |
description |
CYP2E1 enzyme is related to nonalcoholic steatohepatitis (NASH) due to its ability for reactive oxygen species production, which can be influenced by polymorphisms in the gene. The aim of this study was to investigate hepatic levels, activity, and polymorphisms of the CYP2E1 gene to correlate it with clinical and histological features in 48 female obese NASH patients. Subjects were divided into three groups: (i) normal; (ii) steatosis; and (iii) steatohepatitis. CYP2E1 protein level was assayed in microsomes from liver biopsies, and in vivo chlorzoxazone hydroxylation was determined by HPLC. Genomic DNA was isolated for genotype analysis through PCR. The results showed that liver CYP2E1 content was significantly higher in the steatohepatitis (45%; p=0.024) and steatosis (22%; p=0.032) group compared with normal group. Chlorzoxazone hydroxylase activity showed significant enhancement in the steatohepatitis group (15%, p=0.027) compared with the normal group. c2 rare allele of RsallPstl polymorphisms but no C allele of Dral polymorphism was positively associated with CHZ hydroxylation, which in turn is correlated with liver CYP2E1 content (r=0.59; p=0.026). In conclusion, c2 allele is positively associated with liver injury in NASH. This allele may determine a higher transcriptional activity of the gene, with consequent enhancement in pro-oxidant activity of CYP2E1 thus affording liver toxicity |
author |
VARELA,NELSON M QUIÑONES,LUIS A ORELLANA,MYRIAM PONIACHIK,JAIME CSENDES,ATTILA SMOK,GLADYS RODRIGO,RAMÓN CÁCERES,DANTE D VIDELA,LUIS A |
author_facet |
VARELA,NELSON M QUIÑONES,LUIS A ORELLANA,MYRIAM PONIACHIK,JAIME CSENDES,ATTILA SMOK,GLADYS RODRIGO,RAMÓN CÁCERES,DANTE D VIDELA,LUIS A |
author_sort |
VARELA,NELSON M |
title |
Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women |
title_short |
Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women |
title_full |
Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women |
title_fullStr |
Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women |
title_full_unstemmed |
Study of Cytochrome P450 2E1 and its allele Variants in Liver Injury of Nondiabetic, Nonalcoholic Steatohepatitis Obese Women |
title_sort |
study of cytochrome p450 2e1 and its allele variants in liver injury of nondiabetic, nonalcoholic steatohepatitis obese women |
publisher |
Sociedad de Biología de Chile |
publishDate |
2008 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602008000100010 |
work_keys_str_mv |
AT varelanelsonm studyofcytochromep4502e1anditsallelevariantsinliverinjuryofnondiabeticnonalcoholicsteatohepatitisobesewomen AT quinonesluisa studyofcytochromep4502e1anditsallelevariantsinliverinjuryofnondiabeticnonalcoholicsteatohepatitisobesewomen AT orellanamyriam studyofcytochromep4502e1anditsallelevariantsinliverinjuryofnondiabeticnonalcoholicsteatohepatitisobesewomen AT poniachikjaime studyofcytochromep4502e1anditsallelevariantsinliverinjuryofnondiabeticnonalcoholicsteatohepatitisobesewomen AT csendesattila studyofcytochromep4502e1anditsallelevariantsinliverinjuryofnondiabeticnonalcoholicsteatohepatitisobesewomen AT smokgladys studyofcytochromep4502e1anditsallelevariantsinliverinjuryofnondiabeticnonalcoholicsteatohepatitisobesewomen AT rodrigoramon studyofcytochromep4502e1anditsallelevariantsinliverinjuryofnondiabeticnonalcoholicsteatohepatitisobesewomen AT caceresdanted studyofcytochromep4502e1anditsallelevariantsinliverinjuryofnondiabeticnonalcoholicsteatohepatitisobesewomen AT videlaluisa studyofcytochromep4502e1anditsallelevariantsinliverinjuryofnondiabeticnonalcoholicsteatohepatitisobesewomen |
_version_ |
1718441429684977664 |